Emerging roles of m6A RNA modification in cancer therapeutic resistance
Abstract Marvelous advancements have been made in cancer therapies to improve clinical outcomes over the years. However, therapeutic resistance has always been a major difficulty in cancer therapy, with extremely complicated mechanisms remain elusive. N6-methyladenosine (m6A) RNA modification, a hot...
Main Authors: | Wei-Wei Liu, Zhong-Yuan Zhang, Fei Wang, Hao Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-02-01
|
Series: | Experimental Hematology & Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40164-023-00386-2 |
Similar Items
-
The role of m6A methylation in therapy resistance in cancer
by: Hengzhao Zhuang, et al.
Published: (2023-06-01) -
Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy
by: Angel Guan, et al.
Published: (2024-04-01) -
Roles and therapeutic implications of m6A modification in cancer immunotherapy
by: Juan Pan, et al.
Published: (2023-03-01) -
Comprehensive analysis of m6A modification in immune infiltration, metabolism and drug resistance in hepatocellular carcinoma
by: Yunxing Shi, et al.
Published: (2024-04-01) -
Roles and implications of mRNA N6‐methyladenosine in cancer
by: Lingxing Zeng, et al.
Published: (2023-07-01)